Published in Medical Letter on the CDC and FDA, February 25th, 2007
"By focusing on the excitation and emission wavelengths of the geminal diamine intermediate, we were able to monitor the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.